The era of brain chips: China opens up the market, Musk follows suit
China approves the world's first commercial brain chip. Neuralink remains technologically ahead, but Beijing has already won the regulatory race.
There is a date that risks going almost unnoticed beneath the usual avalanche of tech headlines, yet it may well represent a watershed moment in the history of neurology and artificial intelligence applied to the human body. China has become the first country in the world to grant commercial approval to a brain-computer implant. It is called NEO, developed by Chinese company Neuracle, and its official approval — which occurred in the months leading up to June 11, 2026 — marks a clear before and after in this field.
The stated objective is as noble as it is concrete: to help people living with paralysis or severe spinal injuries recover part of their motor capabilities, enabling them to control external devices — from a cursor on a screen to a robotic arm — directly through thought alone. A promise medicine has pursued for decades, and one that now finds, for the first time, a fast track toward the real market.
But the feature that likely convinced Chinese regulatory authorities to accelerate the process concerns the structure of the device itself. Unlike Neuralink, Elon Musk's celebrated company, which involves inserting hundreds of electrodes directly into the cerebral cortex, NEO takes a significantly less invasive approach. Its sensors rest on the brain's protective membrane — the dura mater — without penetrating neural tissue. This has considerably reduced surgical risks and, consequently, simplified the path to approval.
According to Chinese authorities, the device has already completed dozens of clinical trials. The Beijing government makes no secret of its ambitions: the brain-computer interface sector has been included among the strategic industries of the next five-year plan, confirming that this technology is not merely a medical matter but a pillar of global geopolitical and technological competition.
Many international media outlets have read this news as a defeat for Musk. But the reality, as is often the case, is more nuanced. Even some Chinese companies in the sector openly acknowledge that Neuralink maintains a roughly three-year technological lead in the most advanced brain interfaces. The American chip is more sophisticated, more precise, capable of reading neurological signals with a resolution that NEO, for now, does not match.
Yet Beijing has won something equally important: speed. It has demonstrated that it is possible to transform a still-experimental technology into an approved, commercialized product in timeframes that the West, with its more cautious and fragmented regulatory systems, would have struggled to replicate. And in the economy of innovation, whoever reaches the market first — even with a slightly less evolved product — often sets the rules of the game for years to come.
The impact on artificial intelligence is direct and profound. Brain-computer interfaces represent the next evolutionary leap in human-machine interaction. If today we communicate with AI through keyboards and microphones, tomorrow we may do so directly through thought. Every advance in this field brings that frontier closer. And the commercial approval of NEO, however limited its current application, is an unambiguous signal that this frontier is no longer science fiction.
The question that now arises is not who has the better chip. It is who can bring the future into the present most effectively. And right now, the answer appears to be Beijing.